The US etonogestrel implant mandatory clinical training and active monitoring programs: 6-year experience
![For the first time, a drugmaker is seeking FDA approval for an over-the-counter birth control pill - CBS News For the first time, a drugmaker is seeking FDA approval for an over-the-counter birth control pill - CBS News](https://assets2.cbsnewsstatic.com/hub/i/r/2022/06/26/b2f294bc-4577-444b-ab7f-dad13c875a17/thumbnail/1280x720/bb7322ccba0b3449667250824538b8ec/cbsn-fusion-women-health-care-providers-prepare-for-what-comes-next-after-roe-v-wade-was-overturned-thumbnail-1089486-640x360.jpg)
For the first time, a drugmaker is seeking FDA approval for an over-the-counter birth control pill - CBS News
Hormones and Pharmaceuticals in Groundwater Used As a Source of Drinking Water Across the United States | Environmental Science & Technology
![PDF) Assessing the pregnancy protective impact of scheduled non-adherence of a novel progestin-only pill: a study protocol for a prospective, multi-centered, randomized, cross-over study. (Preprint) PDF) Assessing the pregnancy protective impact of scheduled non-adherence of a novel progestin-only pill: a study protocol for a prospective, multi-centered, randomized, cross-over study. (Preprint)](https://i1.rgstatic.net/publication/351474695_Assessing_the_pregnancy_protective_impact_of_scheduled_non-adherence_of_a_novel_progestin-only_pill_a_study_protocol_for_a_prospective_multi-centered_randomized_cross-over_study_Preprint/links/60bf8c4f299bf1e6b71b69be/largepreview.png)
PDF) Assessing the pregnancy protective impact of scheduled non-adherence of a novel progestin-only pill: a study protocol for a prospective, multi-centered, randomized, cross-over study. (Preprint)
![Reaching 'Transformation' In Turnaround Phase 1, Perrigo Looks To Build On Its Accomplishments :: HBW Insight Reaching 'Transformation' In Turnaround Phase 1, Perrigo Looks To Build On Its Accomplishments :: HBW Insight](https://hbw.pharmaintelligence.informa.com/-/media/editorial/hbw-insight/2023/03/hbw2302_prgo_f.jpg?rev=8e8b641332444fb284a108fef1bd0d17)